In-Vivo Contract Research Organization Market Estimated to Expand at a Robust CAGR over 2024
Given high competition in development of mABs the CROs are increasing focus on development of biosimilars. Pipeline focus is shifting from development of standard format mABs to development of bispecifics or, biosimilars. With increasing demand for clinical scale manufacturing of active pharmaceutical ingredients, integrated contract research, development, and manufacturing organizations (CDMOs) are gaining wider revenue footprint across all regions.
View full press release